Nanomedicine in Cancer Immunotherapy

著者名：Kesharwani PhD, Prashant (EDT)

Academic Press（2024/01/11発売）

• 言語：ENG
• ISBN：9780443187704
• eISBN：9780443187711

Description

Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient.This book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each and tailor their selection to their needs. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.Nanomedicine in Cancer Immunotherapy is an interesting reference for those working in the fields of nanotechnology, immunology and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.- Provides a single source for a review of the latest research in the development of nanomaterials for cancer immunotherapy- Introduces the reader to basic principles of immunology and immunotherapy to aid our understanding- Details a wide range of nanomaterial classes for cancer immunotherapy, with advantages and disadvantages thoroughly analyzed

Table of Contents

1. Immunoadjuvants for cancer immunotherapy2. Nanotechnology as an emerging option in cancer immunotherapy3. Different administration routes for nanovectors in cancer immunotherapy4. Two-dimensional materialbased nanomedicines for cancer immunotherapy5. Hydrogel-based nanomedicines for cancer immunotherapy6. Exosomes-based nanomedicines for cancer immunotherapy7. Lipid-based nanomedicines for cancer immunotherapy8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy9. Liposome-based nanomedicines for cancer immunotherapy10. Biomembrane-based nanoparticles for cancer immunotherapy11. Dendrimer-based nanomedicines for cancer immunotherapy12. Magnetic nanocarriers for cancer immunotherapy13. Inhaled delivery of immunotherapy for treatment of lung cancer14. Nano-based vaccination and their administration routes in cancer immunotherapy15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy